Mortality in schizophrenia: clinical and serological predictors
Open accessAbstract
Persons with schizophrenia have a reduced life expectancy largely due to death from natural causes. Factors that have been previously associated with excess mortality include cigarette smoking and antipsychotic medication. The role of other environmental factors such as exposure to infectious agents has been the subject of only limited investigation. We prospectively assessed a cohort of persons with schizophrenia with a clinical evaluation and a blood sample from which antibodies to human herpes viruses and Toxoplasma gondii were measured. Mortality was determined with data from the National Death Index following a period of up to 11 years. We examined the role of demographic, serological, and clinical factors on mortality. A total of 25 (5%) of 517 persons died of natural causes. The standardized mortality ratio was 2.80 (95% CI 0.89, 6.38). After adjusting for age and gender, mortality from natural causes was predicted in separate models by cigarette smoking (relative risk [RR] = 4.66, P = .0029); lower cognitive score (RR = 0.96, P = .013); level of antibodies to Epstein-Barr virus (RR = 1.22, P = .0041) and to Herpes Simplex virus type 1 (RR = 1.19, P = .030); immunologic disease (RR = 3.14, P = .044); and genitourinary disease (RR = 2.70; P = .035). Because cigarette smoking confers an almost 5-fold risk of mortality, smoking cessation is an urgent priority. Having an elevated level of antibodies to Epstein-Barr virus and to Herpes Simplex virus type 1 are also significant predictors of death from natural causes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There was no difference in mortality risk between BME and white British groups beyond what would be expected by chance.
“Although mortality risk was slightly lower in cases from the BME compared with the white British group, in contrast to earlier research,23,24 we found no difference beyond what would be expected by chance.”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [23]
The absence of systematic differences across ethnic groups may be accounted for by social and health disparities in BME populations being offset through greater attention to medical treatment of physical health problems in patients in the care of mental health services.
“the absence of systematic differences across ethnic groups or, as has been reported earlier, an even lower mortality risk in BME groups,23,24 may be accounted for by social and health disparities in BME populations being offset through the, relatively speaking, greater attention to medical treatment of physical health problems in patients in the care of mental health services.”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519 · see citing works
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065 · see citing works
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354 · see citing works
Mcevoy, J., Meyer, J., Goff, D., Nasrallah, H., Davis, S., Sullivan, L., Meltzer, H., Hsiao, J. K., Stroup, T., & Lieberman, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,220 · see citing works
Statistical Methods in Epidemiology
(2012) · Springer eBooks · doi:10.1007/springerreference_205629 · Cited by 1,123 · see citing works
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070 · see citing works
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735 · see citing works
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study
Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050599 · Cited by 619 · see citing works
Life expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518 · see citing works
Life expectancy among persons with schizophrenia or bipolar affective disorder
Laursen, T. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.008 · Cited by 508 · see citing works
Viruses, schizophrenia, and bipolar disorder
Yolken, R. H., & Torrey, Ε. F. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.1.131 · Cited by 356 · see citing works
Self-citationMedical Morbidity and Mortality in Schizophrenia
GOFF, D. C., Cather, C., Evins, A. E., Henderson, D. C., Freudenreich, O., Copeland, P. M., Bierer, M. F., Duckworth, K. S., & Sacks, F. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0205 · Cited by 312 · see citing works
Epstein-Barr virus in autoimmune diseases.
Toussirot, E., & Roudier, J. (2008) · Baillière's Best Practice & Research : Clinical Rheumatology · doi:10.1016/j.berh.2008.09.007 · Cited by 285 · see citing works
Smoking and Mental Illness — Breaking the Link
Prochaska, J. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1105248 · Cited by 271 · see citing works
Infectious agents associated with schizophrenia: A meta-analysis
Arias, I., Sorlózano, A., Villegas, E., Luna, J. D. D., McKenney, K., Cervilla, J. A., Gutiérrez, B., & Fernández, J. G. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.10.026 · Cited by 235 · see citing works
STATISTICAL METHODS IN EPIDEMIOLOGY
Yu, S., & Wang, X. (2017) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789813148963_0018 · Cited by 226 · see citing works
Dickerson, F., Boronow, J. J., Stallings, C. R., Origoni, A. E., Ruslanova, I., & Yolken, R. H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.466 · Cited by 209 · see citing works
Self-citationHui, E. P., Taylor, G. S., Jia, H., Ma, B. B. Y., Chan, S. L., Ho, R., Wong, W.-L., Wilson, S., Johnson, B. F., Edwards, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2448 · Cited by 207 · see citing works
Kilbourne, A. M., Morden, N. E., Austin, K., Ilgen, M. A., McCarthy, J. F., Dalack, G. W., & Blow, F. C. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.07.008 · Cited by 181 · see citing works
Cigarette smoking and mortality risk in people with schizophrenia
Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., Warren, K. R., Feldman, S., Shim, J.-C., Love, R. C., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp152 · Cited by 158 · see citing works
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
Lahti‐Pulkkinen, M., Tiihonen, J., Wildgust, H. J., Beary, M., Hodgson, R. E., Kajantie, E., Osmond, C., Räikkönen, K., & Eriksson, J. G. (2012) · Psychological Medicine · doi:10.1017/s0033291712000396 · Cited by 106 · see citing works
Antiviral treatment for severe EBV infections in apparently immunocompetent patients
Rafailidis, P. I., Mavros, M. N., Kapaskelis, A. M., & Falagas, M. E. (2010) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.07.008 · Cited by 105 · see citing works
A Prevalence Study of Urinary Tract Infections in Acute Relapse of Schizophrenia
Miller, B. J., Graham, K. L., Bodenheimer, C. M., Culpepper, N. H., Waller, J. L., & Buckley, P. F. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08050 · Cited by 66 · see citing works
Dickerson, F., Boronow, J. J., Stallings, C. R., Origoni, A. E., & Yolken, R. H. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm005 · Cited by 65 · see citing works
Self-citationMortality and Its Determinants in People With Psychotic Disorder
Suvisaari, J., Partti, K., Perälä, J., Viertiö, S., Saarni, S. E., Lönnqvist, J. K., Saarni, S. I., & Härkänen, T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827ad512 · Cited by 63 · see citing works
Herpes simplex virus: A marker of severity in bacterial ventilator-associated pneumonia
Bouza, E., Giannella, M., Torres, M. V., Catalán, P., Sánchez‐Carrillo, C., Insa, R., & Muñóz, P. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.10.008 · Cited by 54 · see citing works
Fatal Epstein-barr Virus Myocarditis in a Child with Repetitive Myocarditis
HEBERT, M., Yu, C., Towbin, J. A., & Rogers, B. B. (1995) · Pediatric Pathology & Laboratory Medicine · doi:10.3109/15513819509027016 · Cited by 47 · see citing works
Clinical impact of HSV-1 detection in the lower respiratory tract from hospitalized adult patients
Costa, C. S., Sidoti, F., Saldan, A., Sinesi, F., Balloco, C., Simeone, S., Lorusso, M., Mantovani, S., Merlino, C., Solidoro, P., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03882.x · Cited by 46 · see citing works
Schizophrenia and the immune system: Pathophysiology, prevention, and treatment
Richard, M. D., & Brahm, N. C. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110271 · Cited by 46 · see citing works
Epstein–Barr virus myocarditis as a cause of sudden death: two autopsy cases
Ishikawa, T., Zhu, B.-L., Li, D., Zhao, D. H., & Maeda, H. (2005) · International Journal of Legal Medicine · doi:10.1007/s00414-005-0540-1 · Cited by 32 · see citing works
Integrating Tobacco Treatment Into Mental Health Settings
Prochaska, J. J. (2010) · JAMA · doi:10.1001/jama.2010.1759 · Cited by 32 · see citing works
A longitudinal cohort study of elderly women with urinary tract infections
Molander, U., Arvidsson, L., Milsom, I., & Sandberg, T. (2000) · Maturitas · doi:10.1016/s0378-5122(99)00102-4 · Cited by 29 · see citing works
Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort
Brown, S., & Mitchell, C. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0392-6 · Cited by 21 · see citing works
The effect of gender in diagnosing early schizophrenia
Høye, A., Rezvy, G., Hansen, V., & Olstad, R. (2006) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-006-0066-y · Cited by 20 · see citing works
EBV Infection as a Cause of VT: Evaluation by CMR
Mavrogeni, S. I., Spargias, K. S., Bratis, C., Kolovou, G. D., Papadopoulou, E., & Pavlides, G. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.11.022 · Cited by 11 · see citing works
Dickerson, F., Yu, A., Dalcin, A., Jerome, G. J., Gennusa, J. V., Charleston, J. B., Crum, R. M., Campbell, L. M., Oefinger, M., Appel, L. J., et al. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.749829 · Cited by 11 · see citing works
Self-citationEpstein-Barr Virus Myocarditis as the First Symptom of Infectious Mononucleosis
López, S. I. Z., Bermúdez, J. M. V., Lerín, F. J., Fernández, A., Pérez, G., & Fonseca, C. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2719 · Cited by 9 · see citing works
Sabbatani, S., Manfredi, R., Ortolani, P., Trapani, F., & Viale, P. (2012) · PubMed · Cited by 5 · see citing works
Will the Complexities of Dual Diagnosis Be Addressed by Health Care Reform?
Drake, R. E., & Green, A. I. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.750852 · Cited by 4 · see citing works
Hasegawa, D., Kaji, M., Takeda, H., Kawasaki, K., Takahashi, H., Ochiai, H., Morio, T., Omori, Y., Yokozaki, H., & Kosaka, Y. (2009) · Pediatrics International · doi:10.1111/j.1442-200x.2009.02925.x · Cited by 3 · see citing works
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [17]17. First M, Gibbon M, Spitzer RL, Williams JBW. User’s Guide for the SCID-I, Structured Clinical Interview for DSM IV Axis I Disorders. New York: Biometrics Research; 1996. [Google Scholar]
Cited by
Sorted by citations
Premature Mortality Among Adults With Schizophrenia in the United States
Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1737 · Cited by 1,083 · see citing works
Correll, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P. A. P. M., Taipale, H. T., et al. (2022) · World Psychiatry · doi:10.1002/wps.20994 · Cited by 717 · see citing works
Cigarette Smoking by Patients With Serious Mental Illness, 1999–2016: An Increasing Disparity
Dickerson, F., Schroeder, J. R., Katsafanas, E., Khushalani, S., Origoni, A. E., Savage, C. L. G., Schweinfurth, L. A. B., Stallings, C. R., Sweeney, K., & Yolken, R. H. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201700118 · Cited by 191 · see citing works
Self-citationTowards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Miller, B. J., & Goldsmith, D. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.211 · Cited by 182 · see citing works
Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu138 · Cited by 156 · see citing works
Gardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., Keen, A., O'Brien, C., Onagbesan, O., Fung, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715000562 · Cited by 140 · see citing works
Bai, W., Liu, Z., Jiang, Y., Zhang, Q., Rao, W., Cheung, T. C. C., Hall, B. J., & Xiang, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01671-6 · Cited by 127 · see citing works
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Joseph, J., Depp, C., Martin, A. S., Daly, R. E., Glorioso, D. K., Palmer, B. W., & Jeste, D. V. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.019 · Cited by 109 · see citing works
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Orsolini, L., Sarchione, F., Vellante, F., Fornaro, M., Matarazzo, I., Martinotti, G., Valchera, A., Nicola, M. D., Carano, A., Giannantonio, M. D., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180119144538 · Cited by 102 · see citing works
Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia
Dickerson, F., Stallings, C. R., Origoni, A. E., Schroeder, J. R., Katsafanas, E., Schweinfurth, L. A. B., Savage, C. L. G., Khushalani, S., & Yolken, R. H. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv108 · Cited by 80 · see citing works
Self-citationNatural cause mortality in persons with serious mental illness
Dickerson, F., Origoni, A. E., Schroeder, J., Adamos, M. B., Katsafanas, E., Khushalani, S., Savage, C. L. G., Schweinfurth, L. A. B., Stallings, C. R., Sweeney, K., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12880 · Cited by 58 · see citing works
Self-citationCarrillo, G. L., Ballard, V. A., Glausen, T. G., Boone, Z., Teamer, J., Hinkson, C. L., Wohlfert, E. A., Blader, I. J., & Fox, M. A. (2020) · Glia · doi:10.1002/glia.23816 · Cited by 54 · see citing works
Leukocyte telomere length: Effects of schizophrenia, age, and gender
Wolkowitz, O. M., Jeste, D. V., Martin, A. S., Lin, J., Daly, R. E., Reuter, C., & KRAEMER, H. C. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.10.015 · Cited by 47 · see citing works
Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors
Dickerson, F., Origoni, A. E., Schroeder, J. R., Schweinfurth, L. A. B., Stallings, C. R., Savage, C. L. G., Katsafanas, E., Banis, M., Khushalani, S., & Yolken, R. H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.010 · Cited by 47 · see citing works
Self-citationKadra-Scalzo, G., Stewart, R. J., Shetty, H., MacCabe, J. H., Chang, C., Taylor, D. M., & Hayes, R. D. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12906 · Cited by 45 · see citing works
Tobacco smoking and nicotine dependence in first episode and established psychosis
Lally, J., Spaducci, G., Gardner-Sood, P., Atakan, Z., Greenwood, K., Forti, M. D., Ismail, K., Murphy, K. C., Smith, S. M., McNeill, A. D., et al. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.05.002 · Cited by 37 · see citing works
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders
Pollak, T. A., Rogers, J. P., Nagele, R. G., Peakman, M., Stone, J. M., David, A. S., & McGuire, P. K. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby021 · Cited by 35 · see citing works
Kim, W., Jang, S., Chun, S., Lee, T.-H., Han, K., & Park, E. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.5.835 · Cited by 31 · see citing works
Schizophrenia hospitalization in the US 2005–2014
Chen, E., Bazargan‐Hejazi, S., Ani, C., Hindman, D. W., Pan, D., Ebrahim, G., Shirazi, A., & Banta, J. E. (2021) · Medicine · doi:10.1097/md.0000000000025206 · Cited by 30 · see citing works
Gaughran, F., Stahl, D. R., Stringer, D., Hopkins, D., Atakan, Z., Greenwood, K., Patel, A. K., Smith, S. M., Gardner-Sood, P., Lally, J., et al. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.159 · Cited by 28 · see citing works
Dickerson, F., Savage, C. L. G., Schweinfurth, L. A. B., Medoff, D. R., Goldberg, R. W., Bennett, M. E., Lucksted, A. A., Chinman, M., Daumit, G. L., Dixon, L. B., et al. (2015) · Psychiatric Rehabilitation Journal · doi:10.1037/prj0000161 · Cited by 27 · see citing works
Self-citationLin, J., Liang, F., Li, C., & Lu, T. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.01.011 · Cited by 23 · see citing works
White matter lipidome alterations in the schizophrenia brain
Senko, D., Efimova, O., Osetrova, M., Anikanov, N. A., Boyko, M., Sharaev, M., Morozova, A. Y., Zorkina, Y., Кислов, М. А., Kostyuk, G. P., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00542-5 · Cited by 15 · see citing works
Bennett, M. E., Brown, C. H., Li, L., Himelhoch, S. S., Bellack, A. S., & Dixon, L. B. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1104481 · Cited by 15 · see citing works
Travaglini, L. E., Li, L., Brown, C. H., & Bennett, M. E. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.07.005 · Cited by 15 · see citing works
Dickerson, F., Savage, C. L. G., Schweinfurth, L. A. B., Goldberg, R. W., Bennett, M. E., Dixon, L. B., Daumit, G. L., Chinman, M., & Lucksted, A. A. (2015) · Community Mental Health Journal · doi:10.1007/s10597-015-9967-0 · Cited by 12 · see citing works
Self-citationOlaya, B., Moneta, M. V., Plana‐Ripoll, O., & Haro, J. M. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.115037 · Cited by 12 · see citing works
Izquierdo, N. B., Bioque, M., & Bernardo, M. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000153 · Cited by 11 · see citing works
Dickerson, F., Katsafanas, E., Origoni, A. E., Newman, T., Rowe, K. C., Ziemann, R. S., Bhatia, K. S., Severance, E. G., Ford, G. M., & Yolken, R. H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280443 · Cited by 10 · see citing works
Self-citationNatural cause mortality of mental health consumers: A 10‐year retrospective cohort study
Suggett, J., Foster, K., Lakra, V., Steele, M. C., & Furness, T. (2020) · International Journal of Mental Health Nursing · doi:10.1111/inm.12797 · Cited by 10 · see citing works
Caqueo‐Urízar, A., Ponce-Correa, F., Semir-González, C., & Alfonso Urzúa, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133840 · Cited by 8 · see citing works
Carrillo, G. L., Su, J., Cawley, M. L., Wei, D., Gill, S. K., Blader, I. J., & Fox, M. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15770 · Cited by 7 · see citing works
Kowalec, K., Lu, Y., Song, J., Dalman, C., Hultman, C. M., Larsson, H., Lichtenstein, P., & Sullivan, P. F. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01282-1 · Cited by 5 · see citing works
Sambrook, L., Balmer, A., Tait, J., Ashley‐Mudie, P., McIntyre, J. C., Shetty, A., Nathan, R., & Saini, P. (2025) · BJPsych Open · doi:10.1192/bjo.2025.30 · Cited by 3 · see citing works
Liu, L., Zhao, L., Xiao, Z., Sun, L., Fan, H., Hao, M., Zhao, X., Wang, J., Tian, Y., Yao, X., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07263-8 · Cited by 2 · see citing works
Suicidal attempt among patients with schizophrenia: A cross-sectional study from Morocco
Kassal, Y., Fritah, K., Naïla, N., Arji, N., Siham, B., Laboudi, F., Mesfioui, A., Ouanass, A., Tamouza, R., & Hessni, A. E. (2023) · E3S Web of Conferences · doi:10.1051/e3sconf/202341201023 · Cited by 2 · see citing works
Including Underrepresented Subgroups of Smokers in Tobacco Regulation Research
Weinberger, A. H. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw151 · Cited by 2 · see citing works
İpekçioğlu, D., & Kendirlioglu, B. K. (2019) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.4274/btdmjb.galenos.2019.20190214042203 · Cited by 2 · see citing works
Thomas, J. R., McEvoy, J. P., & Miller, B. J. (2019) · Annals of Clinical Psychiatry · doi:10.1177/154733251903100408 · Cited by 2 · see citing works
Salivary Galectin 3 Levels in Schizophrenia Patients
Shoukat, S., Khan, H., Kashif, M., Ali, S. Y., Qamar, S. N., & Maqsood, M. (2024) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2024.02.202 · Cited by 1 · see citing works
Interventions for smoking cessation in inpatient psychiatry settings
Plever, S., Kisely, S. R., Bonevski, B., Siskind, D. J., Yamazaki-Tan, J., Thaker, P., Vos, G., Kim, D., Guillaumier, A., & GARTNER, C. E. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015934 · Cited by 1 · see citing works
Chang, C.-H., Tsai, H.-C., Wu, S., Tan, H.-R., & Liu, W. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.09.025 · Cited by 1 · see citing works
Risk factors for unnatural mortality in persons with serious mental illness
Dickerson, F., Khan, S., Origoni, A. E., Rowe, K. C., Katsafanas, E., Yang, S., Nestadt, P. S., & Yolken, R. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-20405-y · Cited by 1 · see citing works
Self-citationThaker, P., GARTNER, C. E., Kisely, S. R., & Plever, S. (2024) · International Journal of Mental Health Nursing · doi:10.1111/inm.13332 · Cited by 1 · see citing works
Factors Affecting the Management of Somatic Comorbidity in Tunisian Patients with Schizophrenia
Thabet, J. B., Charfi, N., Dalhoum, W., Yaïch, S., Maalej, M., Omri, S., Zouari, L., Zouari, L., Dammak, J., & Maalej, M. A. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-018-9605-4 · Cited by 1 · see citing works
Pettey, D. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4306 · Cited by 1 · see citing works
Toxoplasma induces stripping of perisomatic inhibitory synapsesPreprint
Carrillo, G. L., Ballard, V. A., Glausen, T. G., Boone, Z., Teamer, J., Hinkson, C. L., Wohlfert, E. A., Blader, I. J., & Fox, M. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/788190
Immune processes and risk of psychosis
Al‐Diwani, A., & Pollak, T. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00011-9
ŠIZOFRENIJA SERGANČIOS PACIENTĖS SAVIŽUDIŠKO ELGESIO RAIŠKA. ATVEJO ANALIZĖ
Daubarytė, I., Stukaitė, E., & Kunigėlienė, A. (2023) · Health Sciences · doi:10.35988/sm-hs.2023.224
Fekih‐Romdhane, F., Zaouali, J., Barketi, A., Ghrissi, F., Cheour, M., & Hallit, S. R. (2026) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70350
- Authors
- Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Khushalani, S., & Yolken, R.
- Affiliations
- Sheppard Pratt Health System (US)
- Johns Hopkins University (US)
- Corresponding author
- Dickerson, Faith
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-08-13
- Volume
- 40
- Issue
- 4
- Pages
- 796-803
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC4059441
- OpenAlex
- W2154240268
- Cited by
- 50
- References
- 42
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 3 · 2016: 4 · 2015: 9 · 2014: 1
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- schizophrenia, mortality
- MeSH terms
- Adult, Antibodies, Protozoan, Antibodies, Viral, Cognition Disorders, Herpesvirus 4, Human, Female, Herpesviridae, Herpesviridae Infections, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Schizophrenia, Schizophrenic Psychology, Smoking, Toxoplasma, Toxoplasmosis, United States, Cohort Studies, Herpesvirus 1, Human, Mortality, Premature
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review